Huvitz Co. Ltd (065510) - Net Assets
Based on the latest financial reports, Huvitz Co. Ltd (065510) has net assets worth ₩121.35 Billion KRW (≈ $82.24 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩235.07 Billion ≈ $159.30 Million USD) and total liabilities (₩113.72 Billion ≈ $77.07 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Huvitz Co. Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩121.35 Billion |
| % of Total Assets | 51.62% |
| Annual Growth Rate | 6.82% |
| 5-Year Change | 55.18% |
| 10-Year Change | 76.87% |
| Growth Volatility | 8.74 |
Huvitz Co. Ltd - Net Assets Trend (2011–2024)
This chart illustrates how Huvitz Co. Ltd's net assets have evolved over time, based on quarterly financial data. Also explore Huvitz Co. Ltd assets under control for the complete picture of this company's asset base.
Annual Net Assets for Huvitz Co. Ltd (2011–2024)
The table below shows the annual net assets of Huvitz Co. Ltd from 2011 to 2024. For live valuation and market cap data, see Huvitz Co. Ltd market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩121.79 Billion ≈ $82.53 Million |
+10.14% |
| 2023-12-31 | ₩110.57 Billion ≈ $74.93 Million |
+7.34% |
| 2022-12-31 | ₩103.01 Billion ≈ $69.81 Million |
+17.11% |
| 2021-12-31 | ₩87.96 Billion ≈ $59.61 Million |
+12.07% |
| 2020-12-31 | ₩78.48 Billion ≈ $53.19 Million |
-10.79% |
| 2019-12-31 | ₩87.97 Billion ≈ $59.62 Million |
+4.85% |
| 2018-12-31 | ₩83.90 Billion ≈ $56.86 Million |
+6.64% |
| 2017-12-31 | ₩78.68 Billion ≈ $53.32 Million |
+1.86% |
| 2016-12-31 | ₩77.25 Billion ≈ $52.35 Million |
+12.19% |
| 2015-12-31 | ₩68.86 Billion ≈ $46.66 Million |
+5.72% |
| 2014-12-31 | ₩65.13 Billion ≈ $44.14 Million |
-0.26% |
| 2013-12-31 | ₩65.30 Billion ≈ $44.25 Million |
-0.02% |
| 2012-12-31 | ₩65.32 Billion ≈ $44.26 Million |
+26.40% |
| 2011-12-31 | ₩51.68 Billion ≈ $35.02 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Huvitz Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 44392.1% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩101.43 Billion | 87.77% |
| Common Stock | ₩6.08 Billion | 5.26% |
| Other Components | ₩8.06 Billion | 6.97% |
| Total Equity | ₩115.57 Billion | 100.00% |
Huvitz Co. Ltd Competitors by Market Cap
The table below lists competitors of Huvitz Co. Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Selva Gida Sanayi AS
IS:SELVA
|
$58.02 Million |
|
Nimbus Group AB
ST:BOAT
|
$58.04 Million |
|
GenoFocus Inc
KQ:187420
|
$58.05 Million |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO
|
$58.07 Million |
|
Arrienda Rental Properties SOCIMI SA
MC:YARP
|
$58.01 Million |
|
PASSUS S.A. ZY-1
F:71X
|
$57.96 Million |
|
FORTE MINERALS CORP.
F:2OA
|
$57.96 Million |
|
Gunawan Dianjaya Steel Tbk
JK:GDST
|
$57.95 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Huvitz Co. Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 110,571,048,620 to 115,567,337,070, a change of 4,996,288,450 (4.5%).
- Net income of 8,709,608,030 contributed positively to equity growth.
- Dividend payments of 2,170,979,000 reduced retained earnings.
- Share repurchases of 194,437,000 reduced equity.
- New share issuances of 194,437,000 increased equity.
- Other factors decreased equity by 1,542,340,580.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩8.71 Billion | +7.54% |
| Dividends Paid | ₩2.17 Billion | -1.88% |
| Share Repurchases | ₩194.44 Million | -0.17% |
| Share Issuances | ₩194.44 Million | +0.17% |
| Other Changes | ₩-1.54 Billion | -1.33% |
| Total Change | ₩- | 4.52% |
Book Value vs Market Value Analysis
This analysis compares Huvitz Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.74x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.18x to 0.74x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩6664.40 | ₩7870.00 | x |
| 2017-12-31 | ₩6787.26 | ₩7870.00 | x |
| 2018-12-31 | ₩7237.08 | ₩7870.00 | x |
| 2019-12-31 | ₩7723.44 | ₩7870.00 | x |
| 2020-12-31 | ₩7402.98 | ₩7870.00 | x |
| 2021-12-31 | ₩8296.65 | ₩7870.00 | x |
| 2022-12-31 | ₩9709.39 | ₩7870.00 | x |
| 2023-12-31 | ₩10186.28 | ₩7870.00 | x |
| 2024-12-31 | ₩10624.05 | ₩7870.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Huvitz Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 7.54%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 7.39%
- • Asset Turnover: 0.53x
- • Equity Multiplier: 1.92x
- Recent ROE (7.54%) is below the historical average (9.47%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | 17.98% | 15.38% | 0.84x | 1.40x | ₩3.89 Billion |
| 2012 | 17.87% | 16.42% | 0.80x | 1.36x | ₩4.87 Billion |
| 2014 | 2.27% | 2.16% | 0.60x | 1.76x | ₩-4.69 Billion |
| 2015 | 9.49% | 9.38% | 0.61x | 1.66x | ₩-354.18 Million |
| 2016 | 14.33% | 16.54% | 0.48x | 1.81x | ₩3.34 Billion |
| 2017 | 3.95% | 4.42% | 0.50x | 1.79x | ₩-4.76 Billion |
| 2018 | 8.45% | 8.99% | 0.56x | 1.69x | ₩-1.30 Billion |
| 2019 | 8.95% | 8.95% | 0.58x | 1.73x | ₩-923.08 Million |
| 2020 | -3.47% | -3.89% | 0.45x | 1.98x | ₩-10.57 Billion |
| 2021 | 10.22% | 9.46% | 0.62x | 1.74x | ₩194.87 Million |
| 2022 | 16.58% | 15.60% | 0.62x | 1.72x | ₩6.77 Billion |
| 2023 | 9.02% | 8.47% | 0.59x | 1.82x | ₩-1.08 Billion |
| 2024 | 7.54% | 7.39% | 0.53x | 1.92x | ₩-2.85 Billion |
Industry Comparison
This section compares Huvitz Co. Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $106,498,285,532
- Average return on equity (ROE) among peers: -4.35%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Huvitz Co. Ltd (065510) | ₩121.35 Billion | 17.98% | 0.94x | $58.02 Million |
| Shinhung (004080) | $77.28 Billion | 1.29% | 0.82x | $88.63 Million |
| HansBiomed Corporation (042520) | $33.89 Billion | -92.49% | 2.73x | $258.75 Million |
| JVM Co. Ltd (054950) | $104.90 Billion | 4.97% | 0.55x | $195.14 Million |
| Vieworks Co. Ltd (100120) | $126.17 Billion | 15.56% | 0.09x | $165.07 Million |
| Corentec Co Ltd (104540) | $60.18 Billion | 0.77% | 0.59x | $50.52 Million |
| Humasis Co. Ltd (205470) | $346.73 Billion | 52.67% | 0.35x | $61.42 Million |
| NH SPAC 2 (206640) | $151.09 Billion | 29.36% | 0.27x | $169.86 Million |
| Hana Must SPAC 2 (208370) | $26.92 Billion | -55.25% | 0.69x | $75.64 Million |
| DRTECH Corporation (214680) | $31.33 Billion | 3.98% | 0.59x | $98.45 Million |
About Huvitz Co. Ltd
Huvitz Co., Ltd. develops and sells optometric medical equipment worldwide. The company offers ophthalmic and optical equipment comprising refractive equipment, such as auto ref-keratometers, auto lensmeters, digital refractors, chart projectors, and unit tables; and diagnostic equipment comprising slit lamps, non-contact tonometers, and applanation tonometers, as well as ophthalmologic diagnosti… Read more